4 July 2022 - n November 2021 the TGA commissioned MTP Connect to conduct a stakeholder review of the regulatory framework for gene, cell and tissue therapies in Australia.
The full report has been published, including MTP Connect's major findings and TGA's proposed response to the major recommendations.